Health Press Release – Weekly Newsletter for December 6-13, 2010

Chronic Fatigue Syndrome Patients Run First-ever Ad in The Washington Post

Possible New HIV-like Retrovirus in Blood Supply
CORAL GABLES, Florida, December 6, 2010 – In an unprecedented move, chronic fatigue syndrome (CFS) patients
published a half-page ad in The Washington Post today. The ad brings
attention to new, HIV-like retroviruses, including XMRV, which have been
linked to CFS and aggressive prostate cancer, and have been detected in
healthy blood …. Original article on Gaea Times at  : Chronic Fatigue Syndrome Patients Run First-ever Ad in The Washington Post.

Pfizer Board of Directors Names Ian C. Read President and Chief Executive Officer

Read Succeeds Jeffrey B. Kindler, who has Retired from the Company
NEW YORK, December 6, 2010 – Pfizer Inc. (NYSE: PFE) today announced that its Board of Directors has
elected Ian C. Read, 57, currently head of the Company's global
biopharmaceutical operations, as President, Chief Executive Officer and
Director. Mr. Read succeeds Jeffrey B. Kindler, who has retired …. Source article on Gaea Times at  : Pfizer Board of Directors Names Ian C. Read President and Chief Executive Officer.

Steve Newman Appointed Chief Technical Officer for Menicon Co.

Newman Taking on Worldwide Responsibility for Product Planning, Manufacturing and Technology

NAGOYA, Japan, December 7, 2010 – Menicon Co., Ltd. has announced the appointment of Steven Newman as Chief
Technical Officer for the company.
(Photo: www.newscom.com/cgi-bin/prnh/20101206/MM11663)
Newman joined Menicon with the acquisition of ClearLab's Flat Pack
technology from 1-800 Contacts in …. Read the original article  : Steve Newman Appointed Chief Technical Officer for Menicon Co..

Bill & Melinda Gates Foundation Statement on the Launch of New Meningitis Group A Vaccine

OUAGADOUGOU, Burkina Faso, December 6, 2010 – Tachi Yamada, president of the Bill & Melinda Gates Foundation's Global
Health Program, issued the following statement to mark the launch of
MenAfriVac-a new vaccine against Meningitis Group A-in Burkina Faso:

"MenAfriVac is a tremendous success story for the global health
community. It is the first vaccine … Read this article on Gaea Times at : Bill & Melinda Gates Foundation Statement on the Launch of New Meningitis Group A Vaccine.

Optical Express Announces December HD TV Give-away

Win a 46" Samsung Full HD LED TV This Christmas
GLASGOW, Scotland, December 6, 2010 – Each week during December, to celebrate superior vision, everyone who
attends a FREE laser eye surgery consultation at Optical Express will be
automatically entered into a draw to win one of four fantastic 46" Samsung
Full HD LED TVs.

… Read the original article on Gaea Times at : Optical Express Announces December HD TV Give-away.

Follow-Up Results from Study Comparing SPRYCEL(R) (dasatinib) to Imatinib in First-Line Treatment of Adults with Ph+ CP-CML Demonstrate Improved Response Rates Consistent with 12 Month Data[1]

18-Month Data Presented at 52nd Annual Meeting of the American Society of Hematology[1]

PRINCETON, New Jersey and TOKYO, December 6, 2010 – Bristol-Myers Squibb Company (www.bms.com) (NYSE:BMY) and Otsuka
Pharmaceutical Co., Ltd. today announced 18-month follow-up results from the
Phase 3 DASISION study of SPRYCEL(R) (dasatinib) 100 mg once daily vs.
imatinib (400 mg daily) in the first-line …. Read the original article  : here.

Setting the Record Straight on Hot Flushes – as Women Lift Lid on the Menopause

OXFORD, England, December 6, 2010 – A ground-breaking website today lifts the lid on the menopause – and
could save women from suffering alone, misunderstood by unsympathetic
partners and sniggering workmates.

The new section of award-winning www.healthtalkonline.org features
46 women from all walks of life – who reveal "everything you wanted to know
but were …. Original article  : Setting the Record Straight on Hot Flushes – as Women Lift Lid on the Menopause.

Cinryze(R) (C1 Esterase Inhibitor [Human]) Data Presented at 2010 International Scientific Conference of the World Allergy Organization (WAO)

DUBAI, United Arab Emirates, December 6, 2010 – ViroPharma Incorporated (Nasdaq: VPHM) today announced data in five
poster presentations relating to Cinryze(R) (C1 esterase inhibitor [human])
at the 2010 International Scientific Conference of the World Allergy
Organization (WAO), December 5 through 8 in Dubai, UAE.

This is the first international presentation of these data, …. Source article on Gaea Times at  : Cinryze(R) (C1 Esterase Inhibitor [Human]) Data Presented at 2010 International Scientific Conference of the World Allergy Organization (WAO).

ViroPharma Incorporated and Idis Partner to Facilitate International Access to Certain ViroPharma Therapeutics Through Named Patient Program

EXTON, Pennsylvania and WEYBRIDGE, England, December 6, 2010 – ViroPharma Incorporated (Nasdaq: VPHM) and Idis, the global leader in
developing long-term strategic solutions to therapeutic access, today
announced that the two companies have partnered to facilitate access to
certain ViroPharma products through a named patient program (NPP).
ViroPharma's NPP, developed and managed by Idis, will allow international
healthcare professionals … Read : ViroPharma Incorporated and Idis Partner to Facilitate International Access to Certain ViroPharma Therapeutics Through Named Patient Program.

CIC Chooses MGS as Exclusive Reseller to Achieve eSignature Growth Objective in the Middle East

REDWOOD SHORES, California, December 6, 2010 – (OTC Bulletin Board: CICI) Communication Intelligence Corporation ("CIC")
the leading supplier of electronic signature solutions for business process
automation in the financial industry and the recognized leader in biometric
signature verification announced today the appointment of MGS, certified
reseller partner of OpenText (www.opentext.com/2/global.htm) and a
leading provider of IT consulting and implementation … Read more >>>.

Experts Reach Agreement on the Most Important Attributes of Combination Therapies for Asthma

The Agreement Will Provide Physicians With Much Needed Guidance for Choosing the Best Combination Therapy for Their Asthma Patients

CAMBRIDGE, England, December 6, 2010 – Data presented today at the World Allergy
Organization (WAO) International Conference have shown that: clinical
efficacy, safety, tolerability and speed of onset of a long-acting
Beta2-agonist (LABA), potency of an inhaled corticosteroid (ICS), …. Source article  : Experts Reach Agreement on the Most Important Attributes of Combination Therapies for Asthma.

VELCADE(R) (bortezomib) Administered Subcutaneously Shows Comparable Response Rates and Safety Profile Compared to Intravenous Administration in the Treatment of Relapsed Multiple Myeloma

Data From Another Study Demonstrating the Efficacy of VELCADE Maintenance Monotherapy and Improvements in Quality of Life Presented at the 52nd American Society of Hematology Annual Meeting

BEERSE, Belgium, December 6, 2010 – Janssen Pharmaceutical Companies today announced the results from data
presented at the 52nd American Society for Hematology (ASH) Annual Meeting in
Orlando, which demonstrated … Read : VELCADE(R) (bortezomib) Administered Subcutaneously Shows Comparable Response Rates and Safety Profile Compared to Intravenous Administration in the Treatment of Relapsed Multiple Myeloma.

Torchmark Corporation Declares Dividend

MCKINNEY, Texas, December 6, 2010 – Torchmark Corporation (NYSE: TMK) announced that its Board of Directors
has declared a quarterly dividend of $.16 per share on all of the outstanding
common stock of the Company held of record as of the close of business of the
Company's transfer agent on January 6, 2011. The dividend will be … Original article on : Torchmark Corporation Declares Dividend.

Global Dental Devices and Consumables Market (2010 – 2015) Now Available at ReportsnReports

DALLAS, December 7, 2010 – ReportsnReports announces it will carry Global Dental Devices and
Consumables Market (2010 – 2015) Research Report in its store.

Browse the complete Report on:
www.reportsnreports.com/reports/41940-global-dental-devices-and-
consumables-market-2010-2015.html
(Due to the length of this URL, it may be necessary to copy and paste
this hyperlink into your Internet browser's … Original article on : Global Dental Devices and Consumables Market (2010 – 2015) Now Available at ReportsnReports.

Global Dental Implants Market Research Report now Available ReportsnReports

ReportsnReports Announces it will Carry Global Dental Implants Market Research Report in its Store.

DALLAS, December 7, 2010 – Browse the complete Report on:
www.reportsnreports.com/reports/26644-global-dental-implants-market-20
10-2015.html
(Due to the length of this URL, it may be necessary to copy and paste
this hyperlink into your Internet browser's URL address field. Remove the
space if one exists.)
… Original article on : Global Dental Implants Market Research Report now Available ReportsnReports.

Accumetrics Closes 2010 With Positive Outlook

Pharmaceutical collaboration, GRAVITAS clinical trial results, distribution agreements, and capital financing position Company for continued growth in 2011

SAN DIEGO, December 7, 2010 – Accumetrics, Inc., a privately-held developer and marketer of the
VerifyNow(R) System, the first rapid and easy-to-use point-of-care system for
measuring platelet reactivity to multiple antiplatelet agents, closes 2010
with continued positive medical community and …. Source article  : Accumetrics Closes 2010 With Positive Outlook.

New NIH Guidelines Advocate ImmunoCAP Blood Test to Improve Diagnosis of Food Allergy

UPPSALA, Sweden, December 8, 2010 – New guidelines on diagnosis and management of food allergy issued by the
National Institute of Allergy and Infectious Diseases a part of NIH, supports
a broader use of blood test to improve current clinical practice.
Phadia's ImmunoCAP is recognized for its superior predictive values compared
to other systems. It provides precise, quantitative …. Original article  : New NIH Guidelines Advocate ImmunoCAP Blood Test to Improve Diagnosis of Food Allergy.

The Binding Site Appoints Charles de Rohan as Chief Executive Officer

BIRMINGHAM, England, December 8, 2010 – The Binding Site Corporation Limited ("Binding Site" or "the
Company"), a privately-owned specialist U.K. diagnostics company, today
announces the appointment of Charles de Rohan as Chief Executive Officer.

Charles de Rohan has worked in the diagnostic industry for
more than 17 years and brings significant experience to the … Read the original article on Gaea Times at : The Binding Site Appoints Charles de Rohan as Chief Executive Officer.

Informex and CMS Pharma Present Inaugural CEO Summit of Pharma Manufacturing

First annual CEO Summit will provide forum for senior industry executives to discuss business strategies and trends in Custom Manufacturing of pharmaceutical ingredients

PRINCETON, New Jersey and INGELHEIM, Germany, December 8, 2010 – Informex, the leading meeting place for buyers and sellers of high-value
chemistry for a broad range of applications, and CMS Pharma, the trusted … Read more : Informex and CMS Pharma Present Inaugural CEO Summit of Pharma Manufacturing.

AVESTHAGEN’s First Biosimilar Molecule AVDESP(TM) Completes Clinical Batch Manufacturing in Malaysia, to Move to Clinical Trials

BANGALORE, India, December 8, 2010 – AVESTHAGEN LIMITED, a leading knowledge based life sciences
company pioneering the convergence between Food, Pharma and Population
Genetics, today announced the completion of manufacturing of the clinical
grade material of its first biosimilar molecule- AVDESP(TM) (biosimilar to
Darbepoetin alfa), which will now be moving into Clinical Trials. Inno
Biologics, Malaysia's biopharma CMO has … Original source on Gaea Times at : AVESTHAGEN's First Biosimilar Molecule AVDESP(TM) Completes Clinical Batch Manufacturing in Malaysia, to Move to Clinical Trials.

Elsevier Enables its e-Books to Read Aloud, Increasing Access for People With Print Disabilities

Text-to-Speech Option Enabled for All Elsevier ePub Book Titles
AMSTERDAM, December 8, 2010 – Elsevier, the world-leading publisher of scientific, technical and
medical information products and solutions, announced today that it has
enabled the text-to-speech option on all of its ePub book titles. The
text-to-speech function enables an e-book to read aloud. This will facilitate
access by readers who … Original article on : Elsevier Enables its e-Books to Read Aloud, Increasing Access for People With Print Disabilities.

/C O R R E C T I O N – Phadia/

UPPSALA, Sweden, December 8, 2010 – In the news release, "New NIH Guidelines Advocate ImmunoCAP Blood Test to
Improve Diagnosis of Food Allergy" issued on 8 Dec 2010 10:56 GMT, by
Phadia over PR Newswire, please note that the link after the first paragraph
has been updated to:
(Logo: www.newscom.com/cgi-bin/prnh/20101208/425503 )
Complete, updated release follows:

New …. Original source  : /C O R R E C T I O N — Phadia/.

NNIT Buys ChannelCRM to Better Service Pharma Businesses

NNIT Buys ChannelCRM – a Specialised Vendor of CRM and Industry Specific xRM Solutions

COPENHAGEN, December 8, 2010 – NNIT has bought Danish software house ChannelCRM in order to further
develop our Customer Relationship Management (CRM) offerings devoted to the
pharmaceutical industry.
(Logo: www.newscom.com/cgi-bin/prnh/20101005/412747 )
The pharmaceutical industry demands both …. Source article  : NNIT Buys ChannelCRM to Better Service Pharma Businesses.

Zealand Pharma Receives Milestone Payment From Helsinn Healthcare

ZP1846, a Novel GLP-2 Agonist, Continues to Advance in Clinical Development Under Licensing Agreement

COPENHAGEN, December 9, 2010 – Zealand Pharma A/S (NASDAQ OMX: ZEAL) ("Zealand Pharma" or
"the Company"), a biopharmaceutical company dedicated to the discovery and
development of innovative peptide drugs that recently listed on NASDAQ OMX,
today announces the receipt of a EUR 500,000 (DKK … Original source on Gaea Times at : Zealand Pharma Receives Milestone Payment From Helsinn Healthcare.

Circle Secures GBP50M Funding for Second New-Build Hospital

LONDON, December 9, 2010 – Circle, the employee-owned partnership of clinicians, has today secured
GBP50m to fund its second new-build hospital – CircleReading.

In a deal that signals a breakthrough in the UK development
finance freeze, the site for the hospital has been purchased by the real
estate investment arm for BP's pension fund, …. Original article on Gaea Times at  : Circle Secures GBP50M Funding for Second New-Build Hospital.

Elsevier Offers Scientific Book Content Through Google eBooks

Important Step in Increasing Access to Broader Audience
NEW YORK, December 9, 2010 – Elsevier, the world-leading publisher of scientific, technical and
medical information products and services, announced today that it is
participating in the recently launched Google eBooks store by including a
large selection of Elsevier's eBook titles. Elsevier regards Google eBooks as
a valuable new distribution channel … Read more : Elsevier Offers Scientific Book Content Through Google eBooks.

Transformation at Top of Agenda for CPMRC’s Annual Conference in Jan. 2011

Video Interview of Dee Hock, Founder of VISA, Adds to Overall Conference Focus on Transformational Leadership in Healthcare

GRAND RAPIDS, Michigan, December 9, 2010 – The 19th International Conference (Jan. 19-22, 2011)
(www.cpmrc.com/consortium/conference/) of the CPM Resource Center
(www.cpmrc.com/) (CPMRC), an Elsevier (www.elsevier.com/)
company and leader in assisting healthcare organizations improve practice at
the point of care, will focus …. Source article  : Transformation at Top of Agenda for CPMRC's Annual Conference in Jan. 2011.